About Nutriband
Nutriband (NASDAQ:NTRB) specializes in the development of innovative pharmaceutical and health product technologies, primarily focusing on the application of transdermal and topical delivery systems. The company is dedicated to improving the efficiency and convenience of drug delivery through these cutting-edge methods. Nutriband's projects span across a range of health concerns, aiming to address both common and niche medical needs. With a strong commitment to research and development, Nutriband seeks to continually expand its product portfolio, striving to improve patient outcomes and adherence to medication regimes. The primary objective of Nutriband is to become a key player in the transdermal and topical drug delivery market, enhancing healthcare experiences for patients worldwide.
Snapshot
Operations
Products and/or services of Nutriband
- Transdermal patches for delivering medications across the skin, offering a painless alternative to injections.
- Development of abuse-deterrent patch technologies aimed at combating opioid misuse by preventing non-intended forms of delivery.
- A line of health and fitness supplements designed to support various aspects of wellness and performance.
- Patches for motion sickness, providing relief from nausea and vomiting associated with travel.
- Nutritional patches, offering a novel way to absorb vitamins and minerals through the skin.
- Technology for enhancing the bioavailability of active pharmaceutical ingredients, improving the efficiency of drug delivery systems.
Nutriband executive team
- Mr. Serguei MelnikFounder, President, Company Secretary & Executive Chairman
- Mr. Gareth SheridanFounder, CEO & Director
- Mr. Gerald GoodmanCFO & Chief Accounting Officer
- Dr. Alan Smith Ph.D.COO & President of 4P Therapeutics
- Dr. Jeffrey Patrick Pharm.D.Chief Scientific Officer
- Mr. Michael MyerPresident of Pocono Pharmaceutical
- Mr. Tyler OverkHead of Active Intelligence